期刊文献+

胸腔积液脱落细胞免疫组织化学染色检测相关抗体对胸膜转移性肺腺癌和恶性胸膜间皮瘤的鉴别诊断价值 被引量:6

Value of Immunohistochemical Detection of Relevant Antibodies in the Exfoliated Cells of Pleural Effusion in the Differential Diagnosis of Malignant Pleural Mesothelioma and Metastatic Pulmonary Adenocarcinoma
下载PDF
导出
摘要 目的评估胸腔积液脱落细胞的波形蛋白(vimentin,VIM)、神经特异度钙结合蛋白(calretinin,CR)、细胞角蛋白7(CK7)、甲状腺转录因子-1(thyroid transcription factor-1,TTF-1)免疫组织化学染色在胸膜转移性肺腺癌和恶性胸膜间皮瘤鉴别诊断中的价值。方法收集我科2009年9月—2011年10月经胸腔积液细胞学诊断或胸膜活检病理学证实的42例恶性胸膜间皮瘤(11例)和胸膜转移性肺腺癌(31例)患者纳入分析。计算胸腔积液脱落细胞免疫组织化学染色中VIM、CR、CKT和TTF-1 4项指标诊断胸膜转移性肺腺癌和恶性胸膜间皮瘤的灵敏度和特异度,评估4项指标在鉴别诊断中的应用价值。结果恶性胸膜间皮瘤患者的VIM、CR、CK7、TTF-1的阳性表达率与胸膜转移性肺腺癌患者比较,差异均有统计学意义(P<0.05)。VIM在恶性胸膜间皮瘤诊断中的灵敏度为91%(10/11),特异度为52%(16/31),阳性预测值为40.0%,阴性预测值为94.1%。CR在恶性胸膜间皮瘤诊断中的灵敏度为82%(9/11),特异度为84%(26/31),阳性预测值为62.9%,阴性预测值为92.9%。CK7在胸膜转移性肺腺癌诊断中的灵敏度为94%(29/31),特异度为82%(9/11),阳性预测值为81.8%,阴性预测值为76.3%。TTF-1在胸膜转移性肺腺癌诊断中的灵敏度为77%(24/31),特异度为91%(10/11),阳性预测值为96.0%,阴性预测值为58.8%。结论胸腔积液脱落细胞的VIM、CR、CKT和TTF-1免疫组织化学染色对恶性胸膜间皮瘤和胸膜转移性肺腺癌的鉴别诊断具有较高应用价值。 Objective To assess the values of the immunochemistry staining of vimentin ( VIM), calretinin ( CR), cytokeratin7 ( CK7), and thyroid transcription factor - 1 ( TTF - 1 ) in the differential diagnosis of malignant pleura1 mesothelio- ma (MPM) and metastatic pulmonary adenocarcinoma (MPA). Methods Totally 11 MPM patients and 31 MPA patients who were treated in our department from September 2009 to October 2011 were enrolled in this study. The levels of VIM, CR, CK7, and TTF - 1 in the exfoliated cells of pleura1 effusion were determined using immunohistochemical method to evaluate their speci- ficity and sensivitiy in the differential diagnosis of MPM and MPA. Results The expressions of VIM, CR, CK, and TTF - 1 showed significant differences between the MPM group and MPA group ( P 〈 0. 05 ). The sensitivity, specificity, positive predic- tive value, and negative predictive value of VIM for the diagnosis of MPM were 91% , 52% ( 16/31 ), 40. 0% , 94. 1%, re- spectively, and those of CR were 82% (9/11), 84% (26/31), 62.9%, 92.9% respectively. The diagnosis sensitivity, specificity, positive predictive value, and negative predictive value of CK7 for the diagnosis of MPA were 94% (29/31), 82% (9/11), 81.8%, 76. 3%, respectively, and those of TTF - 1 were 77% (24/31), 91% ( 10/11 ), 96. 0%, and 58.8%, respectively. Conclusion The immunohistochemistry of VIM, CR, CK7, and TTF - 1 in the exfoliated cells of pleural effusion is valuable for the differential diagnosis of MPM and MPA.
出处 《中国全科医学》 CAS CSCD 北大核心 2012年第35期4075-4078,共4页 Chinese General Practice
关键词 恶性胸膜间皮瘤 肺腺癌 波形蛋白 神经特异度钙结合蛋白 细胞角蛋白7 甲状腺转录因子-1 Malignant pleural mesothelioma Lung adenocarcinoma Vimentin Calretinin Cytokeratin 7 Thyroid transcription factor - 1
  • 相关文献

参考文献14

  • 1Irani DR, Underwood RD, Johnson EH, et al. Malignant pleural effu-sions :a clinical cytopathologic study [J]. Arch Intern Med, 1987,147 (6) : 1133 -1136.
  • 2Alemdn C, Sanchez L, Alegre J, et al. Differentiating between malig-nant and idiopathic pleural effusions : the value of diagnostic procedures[J]. QJM, 2007, 100 (6) : 351 -359.
  • 3Porcel JM, Vives M. Etiology and pleural fluid characteristics of largeand massive effusions [J]. Chest, 2003, 124 (3): 978 -983.
  • 4Ikeda K, Tate G, Suzuki T, et al. Comparison of immunocytochemicalsensitivity between formalin - fixed and alcohol - fixed specimens revealsthe diagnostic value of alcohol - fixed cytocentrifuged preparations in ma-lignant effusion cytology [ J ]. Am J Clin Pathol, 2011, 136 ( 6 ):934 -942.
  • 5Bagheri R,Haghi SZ,Rahim MB,et al. Malignant pleural mesotheli-oma: clinicopathologic and survival characteristic in a consecutive seriesof40 patients [J]. Ann Thorac Cardiovasc Surg, 2011,17 (2):130 -136.
  • 6Renshaw AA, Dean BR, Antman KH, et al. The role of cytologicevaluation of pleural fluid in the diagnosis of malignant mesothelioma[J]. Chest, 1997,111 (1): 106-109.
  • 7Metintas M,Ak G,Dundar E,et al. Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients withpleural effusions: a randomized, controlled trial [ J ]. Chest, 2010,137 (6) : 1362 -1368.
  • 8Kolschmann S, Ballin A, Gillissen A. Clinical efficacy and safety ofthoracoscopic talc pleurodesis in malignant pleural effusions [ J ].Chest, 2005,128 (3) : 1431 -1435.
  • 9Maskell NA,Butland RJ. BTS guidelines for the investigation of a uni-lateral pleural effusion in adults [J]. Thorax, 2003,58 ( Suppl 2):ii8 -iil7.
  • 10Ren S, Terman DS, Bohach G, et al. Intrapleural staphylococcal su-perantigen induces resolution of malignant pleural effusions and a sur-vival benefit in non - small cell lung cancer [ J ]. Chest, 2004, 126(5) : 1529 -1539.

二级参考文献13

  • 1王红梅,周小鸽.TTF-1在肺癌诊断及鉴别诊断中的应用价值[J].诊断病理学杂志,2005,12(6):441-443. 被引量:35
  • 2Moldvay J, Jaekel M, Bogos K, et al. The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas[ J]. Pathol Oncol Res, 2004,10(2) :85 -88.
  • 3Hecht J L, Pinkus J L, Weinstein L J, et al. The value of TTF-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin[J]. Am J Clin Pathol, 2001,116(4) :483 -488.
  • 4Yatabe Y, Mitsudomi T, Takahashi T. TTF-1 expression in pulmonary adenocarcinomas [ J ]. Am J Surg Pathol , 2002, 26 ( 6 ) : 767 - 773.
  • 5Mendelson C R. Role of transcription factors in fetal lung development and surfactant protein gene expression [ J ]. Annu Rev Physiol, 2000, 62:875 -915.
  • 6Myong N H. Thyroid transcription factor-1 ( TTF-1 ) expression in human lung carcinomas : its prognostic implication and relationship with expression of p53 and Ki67 proteins [ J ]. J Korean Med Sci, 2003, 18(4) : 494 -500.
  • 7Kaufmann O, Dietel M. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B [J]. Histopathology , 2000,36(1) : 8-16.
  • 8Travis W D, Colby T V, Corrin B, et al. WHO Histological typing of lung and pleural tumors [ M ]. 3 rd ed, Berlin : Springer, 1999 : 35.
  • 9Goldstein N S, Thomas M. Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies [ J ]. Am J Clin Pathol,2001,116: 319 -325.
  • 10Bejarano P A, Baughman R P, Biddinger P W, et al. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas [ J ]. Mod Pathol, 1996, 9 (4) : 445 - 452.

共引文献7

同被引文献35

  • 1张艳梅,付红,张颖.免疫组化在胸膜上皮性恶性肿瘤鉴别诊断中的价值[J].中国肺癌杂志,2007,10(4):320-323. 被引量:8
  • 2王浩,厉周,黄宗海.恶性腹膜间皮瘤的诊治体会[J].第一军医大学学报,2004,24(8):965-966. 被引量:8
  • 3刘复生.中国肿瘤病理学分类[M].北京:科学技术文献出版社,2001.225-226.
  • 4顾志冬,郑子佳,毛客自,樊绮诗.肿瘤标志物在鉴别伴有胸水的良恶性肺部疾病中的应用价值[J].诊断学理论与实践,2007,6(4):309-314. 被引量:13
  • 5Padgent DM,Cathro HP,Wick MR, et al. Podoplanin is a better immunohistochemical marker for sarcomatoid [ J ]. Am J Surg Pathol, 2008,32 ( 1 ) : 123 - 127.
  • 6Wieczorek TJ, Krane JF. Diagnostic utility of calretinin Immunohistoehemistry in cytologic cell block preparations [ J ]. Cancer,2000,90(5 ) :312 - 319.
  • 7Lozano MD, Panizo A,Toledo GR,et al. 1 mmunoeytoehemistry in the differential diagnosis of serous effusions [ J ]. Cancer,2001,93 (1) :68 -72.
  • 8Myong NH. Thyroid transcription factor-1 ( TTF-1 ) expression in hu- man lung carcinomas:its prognostic implication and relationship with expression of p53 and Ki-67 proteins[ J]. J Korean Med Sci,2003,18 (4) :494-500.
  • 9Kaufmann O, Dietel M. Thyroid transerip tion factor-1 is the superior immunohistochemieal marker for pulmonary adenocareinomas and large cell carcinomas compared to surfactant proteinsA and B [ J ]. Histopathology,2000,36( 1 ) :8-16.
  • 10杨霞,姚宇琪,王娟.液基细胞学(LPT)在体腔积液检查诊断中的应用[J].中国实验诊断学,2009,13(2):194-196. 被引量:3

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部